For patients with rare diseases, connecting virtually with specialists across state lines can be the only option for excellent care. So why are state-licensing restrictions being enforced more aggressively than ever?
Funding and Disclosures
Disclosure forms provided by the authors are available at NEJM.org.
This article was published on August 27, 2022, at NEJM.org.
Print Subscriber? Activate your online access.